Prevention of Schizophrenia: Can it Be Achieved?

Author： Cheng Lee Thomas H. McGlashan Scott W. Woods

ISSN： 1172-7047

Source： CNS Drugs, Vol.19, Iss.3, 2005-01, pp. : 193-206

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Corticosteroid Avoidance in Pediatric Renal Transplantation: Can it Be Achieved?

By Jayakumar R. Vidhun Minnie M. Sarwal

Pediatric Drugs, Vol. 6, Iss. 5, 2004-01 ,pp. : 273-287

Adis International

Access to resources Recommend Favorite

Changing Prescribing in the Light of Tolerability Concerns: How is This Best Achieved?

By de Vries C.S.

Drug Safety, Vol. 21, Iss. 3, 1999-09 ,pp. : 153-160

Adis International

Access to resources Recommend Favorite

Best options for schizophrenia in Slovenia?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 545, 2008-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Bifeprunox: beneficial in schizophrenia?

Inpharma, Vol. 1, Iss. 1570, 2007-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

Predictor of treatment response in schizophrenia?

Inpharma, Vol. 1, Iss. 1280, 2001-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite